- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. 103311Publication without faculty affiliation
- Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial2021 | Second Faculty of Medicine
- CD19 expression in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia pre- and post-treatment with blinatumomab2021 | Second Faculty of Medicine
- Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high-risk first relapse B-cell precursor acute lymphoblastic leukemia2022 | Second Faculty of Medicine
- Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia2023 | Second Faculty of Medicine
- Blinatumomab consolidation and maintenance therapy in adults with relapsed/refractory B-precursor acute lymphoblastic leukemia2020 | Publication without faculty affiliation
- Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL2023 | Second Faculty of Medicine
- CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment2017 | Second Faculty of Medicine
- Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment2015 | Second Faculty of Medicine
- Current Approaches in Cancer Immunotherapy2015 | First Faculty of Medicine
- Recent advances in the management of pediatric acute lymphoblastic leukemia2016 | Second Faculty of Medicine